These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16920618)

  • 21. LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome.
    Fukuchi K; Katsuya T; Sugimoto K; Kuremura M; Kim HD; Li L; Ogihara T
    J Med Genet; 2004 May; 41(5):e67. PubMed ID: 15121795
    [No Abstract]   [Full Text] [Related]  

  • 22. Hutchinson-Gilford progeria syndrome caused by an LMNA mutation: a case report.
    Chu Y; Xu ZG; Xu Z; Ma L
    Pediatr Dermatol; 2015; 32(2):271-5. PubMed ID: 25556323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of the genetic premature aging disease Hutchinson Gilford progeria syndrome reveals differential protein expression and glycosylation.
    Robinson LJ; Karlsson NG; Weiss AS; Packer NH
    J Proteome Res; 2003; 2(5):556-7. PubMed ID: 14582653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.
    Huang S; Risques RA; Martin GM; Rabinovitch PS; Oshima J
    Exp Cell Res; 2008 Jan; 314(1):82-91. PubMed ID: 17870066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere length in Hutchinson-Gilford progeria syndrome.
    Decker ML; Chavez E; Vulto I; Lansdorp PM
    Mech Ageing Dev; 2009 Jun; 130(6):377-83. PubMed ID: 19428457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hutchinson-Gilford progeria syndrome with scleroderma-like skin changes due to a homozygous missense LMNA mutation.
    Zhang S; Zhang K; Jiang M; Zhao J
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):463-5. PubMed ID: 25371241
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome.
    Santiago-Fernández O; Osorio FG; Quesada V; Rodríguez F; Basso S; Maeso D; Rolas L; Barkaway A; Nourshargh S; Folgueras AR; Freije JMP; López-Otín C
    Nat Med; 2019 Mar; 25(3):423-426. PubMed ID: 30778239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
    Huang S; Chen L; Libina N; Janes J; Martin GM; Campisi J; Oshima J
    Hum Genet; 2005 Dec; 118(3-4):444-50. PubMed ID: 16208517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neonatal progeroid syndrome (Wiedemann-Rautenstrauch): a model for the study of human aging?
    Arboleda G; Ramírez N; Arboleda H
    Exp Gerontol; 2007 Oct; 42(10):939-43. PubMed ID: 17728088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
    Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
    Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Towards gene therapy for Progeria ?].
    Jordan B
    Med Sci (Paris); 2021 Apr; 37(4):413-416. PubMed ID: 33908864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell depletion in Hutchinson-Gilford progeria syndrome.
    Rosengardten Y; McKenna T; Grochová D; Eriksson M
    Aging Cell; 2011 Dec; 10(6):1011-20. PubMed ID: 21902803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes.
    Ding SL; Shen CY
    Clin Interv Aging; 2008; 3(3):431-44. PubMed ID: 18982914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.
    Beyret E; Liao HK; Yamamoto M; Hernandez-Benitez R; Fu Y; Erikson G; Reddy P; Izpisua Belmonte JC
    Nat Med; 2019 Mar; 25(3):419-422. PubMed ID: 30778240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
    Scaffidi P; Misteli T
    Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bioinformatics analysis of Lamin-A regulatory network: a perspective on epigenetic involvement in Hutchinson-Gilford progeria syndrome.
    Arancio W
    Rejuvenation Res; 2012 Apr; 15(2):123-7. PubMed ID: 22533413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina.
    Korf B
    N Engl J Med; 2008 Feb; 358(6):552-5. PubMed ID: 18256390
    [No Abstract]   [Full Text] [Related]  

  • 39. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases.
    Kudlow BA; Kennedy BK; Monnat RJ
    Nat Rev Mol Cell Biol; 2007 May; 8(5):394-404. PubMed ID: 17450177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1824T mutation in the LMNA gene has no association with senile cataract.
    Sadikov T; Simon AJ; Avraham-Lubin BC; Dratviman-Storobinsky O; Cohen Y; Goldenberg-Cohen N
    Neurobiol Aging; 2012 Jul; 33(7):1487.e15-9. PubMed ID: 22079058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.